AI/ML Innovations Inc. Completes Financing for Total Gross Proceeds of $600,000.00

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) has completed a non-brokered private placement, issuing 4 million units at $0.15 per unit, resulting in $600,000 in gross proceeds. Each unit consists of one common share and one share purchase warrant, exercisable at $0.20 for 12 months. The funds will support platform deployment with healthcare clients and general operating expenses. The company incurred $25,337.81 in finder's fees for this offering.

Positive

• Raised $600,000 through a non-brokered private placement.
• Funds will enhance platform deployment with healthcare clients.
• Warrants provide potential future capital at $0.20 if exercised.

Negative

• Finders' fees of $25,337.81 reduce net funds available.
• Warrants set at $0.20 may not be attractive if stock does not perform.

TORONTO, ON / ACCESSWIRE / March 24, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has completed a non-brokered private placement offering (the "Offering") to identified strategic health technology investors of 4,000,000 units ("Units") at $0.15 per Unit for gross proceeds of $600,000. Each Unit is comprised of one common share and one share purchase warrant, with each warrant having an exercise price of $0.20 and an expiration date of 12 months from the date of issuance, subject to acceleration if AIML trades at $0.30 for 10 consecutive trading days.

The Company intends to use the proceeds of this offering to further advance its platform deployment with key healthcare clients as well as general operating capital. The Company paid finder's fees of $25,337.81 in respect to the Offering.

For more information about AI/ML Innovations:

For detailed information please see AI/ML's website at https://aiml-innovations.com/

or the Company's filed documents at www.sedar.com

Presentations:

Investor slidedeck: https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf

Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be

Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors

Tim Daniels, Executive Chairman

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.

For more information about AI/ML Innovations:

For detailed information please visit our website or our filed documents at www.sedar.com

Presentations:

Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be

Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: AI/ML Innovations Inc.

View source version on accesswire.com:
https://www.accesswire.com/694599/AIML-Innovations-Inc-Completes-Financing-for-Total-Gross-Proceeds-of-60000000

FAQ

What was the gross amount raised by AIMLF in the recent financing?

AI/ML Innovations raised a total of $600,000 through a non-brokered private placement.

What are the terms of the share purchase warrants issued by AIML?

Each unit comes with a share purchase warrant exercisable at $0.20, expiring in 12 months, with acceleration conditions.

How will AI/ML Innovations use the proceeds from the financing?

The proceeds will be used to advance platform deployment with healthcare clients and for general operating capital.

What are the share prices and performance conditions for AIMLF?

The warrants can be exercised if AIML trades at $0.30 for 10 consecutive trading days.